Investor Relations

Overview

A regenerative medicine innovator focused on stem cell-based therapies and products

Latest News

View All News
BioRestorative to Participate in Benzinga All-Access Show Today to Discuss Recent Achievements of Key Clinical & Regulatory Milestones, and Highlight Commercial Opportunities View Press Release
View All News

Latest Presentation

Investor Presentation

Recent Event

Benzinga All-Access Show View Event
View All Events

Latest Financial Results

FY 2024

Fiscal Year Ended Dec 31, 2024

View All Financial Results

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2024

View 10-K

Company Overview

BioRestorative Therapies was founded by scientists and researchers committed to developing stem cell therapies to address unmet needs in patients with highly prevalent conditions.

Our advances in stem cell biology and delivery protocols harbor great promise in conditioning our bodies’ own regenerative potential to treat major diseases more effectively than current interventions.

Stock Snapshots

IR Contacts

Headquarters

BioRestorative Therapies, Inc.
40 Marcus Drive, Suite 1
Melville, NY 11747

Investor Relations

Stephen Kilmer
T: 646-274-3580
skilmer@biorestorative.com

Transfer Agent

Transhare Corporation
Bayside Center 1
17755 North US Highway 19, Suite 140
Clearwater, FL 33764